Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/B6E stock hub

FRA/B6E has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/B6Eis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

13.9B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/B6E

In the news

Latest news · FRA/B6E

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E19.6

P25 n/aP50 n/aP75 n/a

Trailing P/E165.2

P25 n/aP50 n/aP75 n/a

ROE2.3

P25 n/aP50 n/aP75 n/a

ROIC16

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/B6E market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

212

Groups with data

Currency

SEK

Showing 212 of 212 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Sweden
Country code	DE
Employees	1,969
Employees Change	82%
Employees Change Percent	4.54
Enterprise value	EUR 15.5B
Exchange	Frankfurt Stock Exchange
Financial currency	SEK
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 13.9B
Price	EUR 40.14
Price currency	EUR
Rev Per Employee	1,340,256.98x
Sic	2836
Symbol	fra/B6E
Website	https://www.sobi.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.61%
EV Earnings	185.08x
EV/EBIT	19.84x
EV/EBITDA	14.34x
EV/FCF	23.16x
EV/Sales	5.82x
FCF yield	4.84%
Forward P/E	19.6x
P/B ratio	3.77x
P/E ratio	165.18x
P/S ratio	5.25x
PE Ratio10 Y	225.44x
PE Ratio3 Y	689.49x
PE Ratio5 Y	423.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	29.42%
EBITDA Margin	40.29%
FCF margin	25.42%
Gross margin	78.68%
Gross Profit	EUR 2.1B
Gross Profit Growth	10.9%
Gross Profit Growth Q	10.31%
Gross Profit Growth3 Y	15.52%
Gross Profit Growth5 Y	14.91%
Net Income	EUR 83.9M
Net Income Growth	-76.74%
Net Income Growth Q	50.63%
Net Income Growth3 Y	-33.71%
Net Income Growth5 Y	-19.7%
Pretax Margin	2.14%
Profit Margin	3.18%
Profit Per Employee	EUR 42,628
ROA	7.03
Roa5y	5.4
ROCE	14.3
ROE	2.31
Roe5y	8.52
ROIC	15.97
Roic5y	10.66

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	13.84%
Cagr15y	20.86%
Cagr1y	49.15%
Cagr3y	22.71%
Cagr5y	27.25%
EPS Growth	-76.9
EPS Growth Q	49.6
EPS Growth3 Y	-37.04
EPS Growth5 Y	-22.19
FCF Growth	0.01%
FCF Growth Q	-50.92%
FCF Growth3 Y	15.46%
FCF Growth5 Y	9.38%
OCF Growth	-0.42%
OCF Growth Q	-50.94%
OCF Growth10 Y	29.14%
OCF Growth3 Y	14.59%
OCF Growth5 Y	9.31%
Revenue Growth	10.37x
Revenue Growth Q	11.12x
Revenue Growth3 Y	14.87x
Revenue Growth5 Y	15.18x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.38
Assets	EUR 7.4B
Cash	EUR 85.7M
Current Assets	EUR 1.4B
Current Liabilities	EUR 2B
Debt	EUR 1.7B
Debt EBITDA	EUR 1.62
Debt Equity	EUR 0.47
Debt FCF	EUR 2.59
Equity	EUR 3.7B
Interest Coverage	11.95
Liabilities	EUR 3.7B
Long Term Assets	EUR 6B
Long Term Liabilities	EUR 1.7B
Net Cash	EUR -1.7B
Net Cash By Market Cap	EUR -11.91
Net Debt EBITDA	EUR 1.55
Net Debt Equity	EUR 0.45
Net Debt FCF	EUR 2.46
Tangible Book Value	EUR -2B
Tangible Book Value Per Share	EUR -5.66

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.7
Inventory Turnover	1.38
Net Working Capital	EUR 346.5M
Quick ratio	0.47
Working Capital	EUR -583.9M
Working Capital Turnover	EUR -0.79

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.55%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	265.39%
1Y total return	49.11%
200-day SMA	31.04
3Y total return	84.8%
50-day SMA	36.71
50-day SMA vs 200-day SMA	50over200
5Y total return	233.52%
All Time High	40.94
All Time High Change	-1.95%
All Time High Date	2026-05-07
All Time Low	1.24
All Time Low Change	3,126.69%
All Time Low Date	2011-11-23
ATR	0.6
Ch YTD	30.49
High	40.42
High52	40.94
High52 Date	2026-05-07
High52ch	-1.95%
Low	40.14
Low52	23.62
Low52 Date	2025-08-01
Low52ch	69.94%
Ma50ch	9.36%
Price vs 200-day SMA	29.33%
RSI	64.18
RSI Monthly	72.54
RSI Weekly	66.7
Sharpe ratio	1.23x
Sortino ratio	2
Total Return	-0.55%
Tr YTD	30.49
Tr15y	1,615.26%
Tr1m	8.9%
Tr1w	1.16%
Tr3m	9.67%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 776.4M
Operating Income Growth	46.78
Operating Income Growth Q	31.82
Operating Income Growth3 Y	23.01
Operating Income Growth5 Y	17.53
Operating margin	29.42

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	221,914,250%
Net Borrowing	426,755,184.7
Shares Insiders	0.3%
Shares Institutions	42.84%
Shares Qo Q	0.2%
Shares Yo Y	0.55%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 670.7M
Average Volume	19.1x
Bv Per Share	10.64
CAPEX	EUR -3.3M
Ch10y	249
Ch15y	1,538.4
Ch1m	8.9
Ch1w	1.16
Ch1y	49.11
Ch3m	9.67
Ch3y	76.52
Ch5y	218.6
Ch6m	35.06
Change	-1.86%
Change From Open	-0.69
Close	40.9
Days Gap	-1.17
Depreciation Amortization	289,656,171.1
Dollar Volume	200.7
Earnings Date	2026-07-16
EBIT	EUR 776.4M
EBITDA	EUR 1.1B
EPS	EUR 0.24
F Score	7
FCF	EUR 670.7M
FCF EV Yield	4.32x
Financing CF	498,685,013
Fiscal Year End	December
Founded	1,939
Goodwill	1,096,700,096.4
Graham Number	7.63261
Graham Upside	-80.99
Income Tax	EUR -27.3M
Investing CF	-1,179,820,207
Is Primary Listing	0
Last Earnings Date	2026-03-31
Last Report Date	2026-03-31
Lynch Fair Value	EUR 1.22
Lynch Upside	-96.97
Ma150	33.05
Ma150ch	21.47%
Ma20	38.24
Ma20ch	4.97%
Net CF	-5,194,636
Next Earnings Date	2026-07-16
Open	40.42
P FCF Ratio	20.67
P OCF Ratio	20.57
Position In Range	0
Ppne	150,348,851.2
Price Date	2026-05-08
Price EBITDA	EUR 13.04
Relative Volume	0.28x
Revenue	2,638,965,993x
Tax By Revenue	-1.04x
Tr6m	35.06%
Volume	5
Z Score	2.62

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/B6E pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/B6E stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/B6E?

Insider, institutional, and short-interest positioning.

Institutional ownership

+42.8%

Share of float held by funds and institutions

Insider ownership

+0.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.6%

Negative means the company is buying back shares.

Technical

FRA/B6E momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

64.2

Neutral momentum band

Price vs 200-day MA

+29.3%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.23

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/B6E

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/B6E stock rating?

fra/B6E is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/B6E analysis?

The full report lives at /stocks/fra/B6E/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/B6E?

The latest report frames fra/B6E around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/B6E page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.